PolyPid Ltd. (PYPD)
5.15
+0.05
(+0.98%)
USD |
NASDAQ |
Aug 26, 13:21
PolyPid Debt to Equity Ratio : 0.2918 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2918 |
| March 31, 2026 | 0.2669 |
| December 31, 2025 | 0.2548 |
| September 30, 2025 | 0.2823 |
| June 30, 2025 | 0.4234 |
| March 31, 2025 | 102.65 |
| December 31, 2024 | 1.252 |
| September 30, 2024 | 4.641 |
| June 30, 2024 | 6.890 |
| March 31, 2024 | 1.596 |
| December 31, 2023 | -5.620 |
| September 30, 2023 | 3.347 |
| June 30, 2023 | 1.459 |
| Date | Value |
|---|---|
| March 31, 2023 | 1.126 |
| December 31, 2022 | 2.356 |
| September 30, 2022 | 0.9985 |
| June 30, 2022 | 0.4755 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Teva Pharmaceutical Industries Ltd. | 2.176 |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 0.2676 |
| Purple Biotech Ltd. | 0.0109 |
| Sol-Gel Technologies Ltd. | 0.016 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 15.23M |
| Total Liabilities (Quarterly) | 9.846M |
| Shareholders Equity (Quarterly) | 5.388M |
| Current Ratio | 1.346 |
| Net Debt Paydown Yield | 1.41% |